Brochure
13 Oct 2025
R&D Center
JPG 12.2 MB
New R&D Center in Songdo
Content provided by our supplier
Daebong LS
-
Country/Region:Korea, Republic Of
-
On CPHI since:2021
-
Employees:250 - 499
Company types
Other Content from Daebong LS (1)
-
News Daebong Life Science to Showcase Innovative API Developments at CPhI Frankfurt 2025
Daebong LS is pleased to announce its participation in CPhI Frankfurt 2025 on October 28th, where the company will engage in a series of B2B meetings with global partners.
During the event, Daebong LS will highlight its latest research achievements, including:
Efinaconazole Co-crystal
L-Erdosteine
Novel Salt of Azilsartan
Through these presentations, Daebong LS aims to explore opportunities for technology transfer and strengthen collaborations with leading companies in the pharmaceutical industry.
As an active developer of innovative active pharmaceutical ingredients (APIs), Daebong continues to expand its global partnerships and contribute to advancing healthcare solutions.